Cumberland Pharmaceuticals CPIX Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's investing cash flow?
- Cumberland Pharmaceuticals (CPIX) reported investing cash flow of -$61.17K in Q1 2026.
- How has Cumberland Pharmaceuticals's investing cash flow changed year-over-year?
- Cumberland Pharmaceuticals's investing cash flow increased by 95.0% year-over-year, from -$1.23M to -$61.17K.
- What is the long-term trend for Cumberland Pharmaceuticals's investing cash flow?
- Over 2 years (2021 to 2025), Cumberland Pharmaceuticals's investing cash flow has grown at a 215.4% compound annual growth rate (CAGR), from -$501.89K to -$4.99M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.